A man with Alzheimer’s, knowing there’s no cure for the disease, donned a million-dollar helmet for a cutting-edge treatment directing nearly a thousand beams of ultrasound energy at a target in his brain the size of a pencil point. Dan Miller, 61, said he didn’t have anything to lose when he signed up for the … Read more
SEATTLE — A Mount Vernon man was the first to receive the new Alzheimer’s drug, lecanemab, at the University of Washington (UW) Medicine’s Memory and Brain Wellness Center on Dec. 1. “I’m pleased that Harborview Medical Center is one of the first West Coast hospitals to administer the IV infusion treatment to our qualifying patients,” … Read more
Even before the scans and tests, it was clear to everyone that Catriona’s memory was severely failing. Although David Cameron was Prime Minister at the time, Catriona thought it was still Margaret Thatcher. We were finally, gently, told that she had Alzheimer’s. Catriona was prescribed a drug, donepezil, which we were told could stave off … Read more
BOSTON – Researchers at Massachusetts General Hospital in Boston have come up with a way to test your risk for dementia or a stroke. They calculate your odds and if you get regular checkups, it shouldn’t require any blood work, labs or a trip to the doctor. What are the Brain Care Score questions? The … Read more
In a recent review published in Nutrients, researchers reviewed existing data on the interactions between the gut microbiome, lipids, and Alzheimer’s disease (AD), providing valuable insights to inform AD prevention and management. Study: Lipids, Gut Microbiota, and the Complex Relationship with Alzheimer’s Disease: A Narrative Review. Image Credit: Atthapon Raksthaput/Shutterstock.com Background AD is a chronic neurological illness … Read more
In a recent article published in the journal Nature Reviews Neurology, researchers discuss the efficacy of tau-targeting Alzheimer’s disease (AD) therapies and strategies that can be implemented to improve these treatments, especially immunotherapies. Study: Tau-targeting therapies for Alzheimer disease: Current status and future directions. Image Credit: Gorodenkoff / Shutterstock.com Background Since 2018, the prevalence of AD has increased … Read more
Engineers at the University of California San Diego have developed a smartphone attachment that could enable people to screen for a variety of neurological conditions, such as Alzheimer’s disease and traumatic brain injury, at low cost-;and do so accurately regardless of their skin tone. The technology, published in Scientific Reports, has the potential to improve … Read more
Millions of Americans and their doctors are in the dark when it comes to early cognitive decline, according to new research from the University of Southern California. A study out this week suggests that most general physicians vastly under-diagnose mild cognitive impairment among their patients, following another recent study from the same authors which found … Read more
Life expectancy has increased substantially for people in the United States with Down syndrome, from a median age of 4 years old in the 1950s to 57 years old in 2019. This longer life span increases the need for adequate healthcare into adulthood for this population, the majority of whom are at high risk of … Read more
Wearable digital devices that track movement are more effective than clinical observations at tracking the progression of Parkinson’s disease, according to a recent study from researchers at Oxford University. Each subject in the study received six sensors that tracked 122 physiological metrics in total with several dozen metrics such as toe movement and stride length … Read more